(Q67971257)
Statements
[Clinical and pharmacokinetics studies of ceftriaxone upon 2g once daily administration in respiratory tract infections] (English)
S Ishioka
H Yamakido
K Inyaku
K Hasegawa
M Yamakido
T Akagawa
M Kuwabara
Y Kodomari
M Kawamoto